A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Chronic Hepatitis C Virus Infection
Status:
Completed
Trial end date:
2017-02-09
Target enrollment:
Participant gender:
Summary
The purpose of this phase 3, multicenter study is to evaluate the efficacy and safety of
ABT-493/ABT-530 in Japanese adults with chronic Hepatitis C Virus (HCV)-infected, HCV
direct-acting antiviral agent (DAA) treatment-naïve, and DAA treatment-experienced Japanese
adult subjects.